USPTO serial 98806452
ASPEYA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 24, 2026
- Examiner
- HOPKINS, SARAH COLLEEN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ASPEYA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LAUSANNE, CH
LAUSANNE, CH
Vectura Fertin Pharma Switzerland S.A.
Lausanne, CH
Other trademarks owned by Vectura Fertin Pharma Switzerland S.A.
LAUSANNE, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tamar Niv Bessinger
Tamar Niv Bessinger Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, antipyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment of mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment of mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nutraceuticals for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment of mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions being cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for treatment of a wide variety of diseases and conditions being cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum for use as an aid to stop smoking | ACTIVE | — |
| 010 | Medical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices sold empty for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered dose inhalers (pMDI) for therapeutic purposes, sold empty | ACTIVE | — |
| 030 | mixes in the nature of syrups, powders, or concentrates for flavoring being preparation of non-alcoholic beverages being tea based beverages; non-alcoholic beverages, namely, tea | ACTIVE | — |
| 032 | Non-alcoholic beverages, namely, flavored waters and mineral and aerated waters; Pastilles and powders for effervescing beverages, namely, effervescent tablets and powders for making sports drinks and soft drinks; Energy drinks; Isotonic beverages; Protein enriched sports beverages; Whey beverages; Syrups and other preparations for making non-alcoholic beverages, namely, concentrates, syrups, or powders used in the preparation of soft drinks, tea-flavored beverages, and fruit flavored beverages | ACTIVE | — |
| 042 | Medical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; research, and development of inhaled therapeutics; research, and development of pharmaceutical and well-being products for oral and intraoral delivery systems | ACTIVE | — |
| 044 | Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ASPEYA SWITZERLAND SA
- Other trademarks owned by ASPEYA SWITZERLAND SA
- Other trademarks owned by Vectura Fertin Pharma Switzerland S.A.
- Other trademarks owned by ASPEYA SWITZERLAND SA
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 030
- Other trademarks in Class 032
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ASPEYA
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 9, 2026 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Dec 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 30, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 30, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 1, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 1, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 2, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 2, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 2, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 5, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 26, 2024 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Dec 26, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 20, 2024 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Nov 20, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 17, 2024 | NWAP | NEW APPLICATION ENTERED | — |